Biophysical Control of the Glioblastoma Immunosuppressive Microenvironment: Opportunities for Immunotherapy

GBM is the most aggressive and common form of primary brain cancer with a dismal prognosis. Current GBM treatments have not improved patient survival, due to the propensity for tumor cell adaptation and immune evasion, leading to a persistent progression of the disease. In recent years, the tumor mi...

Full description

Bibliographic Details
Published in:	Bioengineering
Main Authors:	Landon Teer, Kavitha Yaddanapudi, Joseph Chen
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Subjects:	glioblastoma immunotherapy tumor microenvironment biophysics
Online Access:	https://www.mdpi.com/2306-5354/11/1/93

Similar Items

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
by: Xuehua Zhang, et al.
Published: (2022-11-01)

Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies
by: Boyuan Huang, et al.
Published: (2023-02-01)

Emerging insights into the immunosuppressive tumor microenvironment and its implications for glioblastoma immunotherapy
by: Niovi Nicolaou, et al.
Published: (2025-10-01)

Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment
by: Dongxin Jiang, et al.
Published: (2025-05-01)

Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy
by: Tingting Wang, et al.
Published: (2022-10-01)

Editorial: Immunosuppression mechanisms and immunotherapy strategies in glioblastoma
by: Sihan Xiong, et al.
Published: (2024-04-01)

Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment
by: Ainhoa Hernández, et al.
Published: (2021-12-01)

Understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase immunotherapy efficacy
by: Jimena Collado, et al.
Published: (2024-02-01)

Combining immunotherapy with radiotherapy for glioblastoma: recent advances and challenges
by: Yuanyang Sun, et al.
Published: (2025-05-01)

Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
by: Frontiers Production Office
Published: (2021-10-01)

Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments
by: Lisa Feldman
Published: (2024-06-01)

Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy
by: Chen Chen, et al.
Published: (2025-03-01)

Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape
by: Zide Wang, et al.
Published: (2022-10-01)

The hotspots and publication trends in glioblastoma and CAR-T immunotherapy: A bibliometric analysis
by: Zhaoming Song, et al.
Published: (2025-12-01)

Immunotherapy in Glioblastoma: An Overview of Current Status
by: Sarfraz Z, et al.
Published: (2025-07-01)

Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches
by: Dev Kumar Tripathy, et al.
Published: (2024-03-01)

Epigenetics and Metabolism Reprogramming Interplay into Glioblastoma: Novel Insights on Immunosuppressive Mechanisms
by: Filippo Torrisi, et al.
Published: (2023-01-01)

Glioblastoma vaccine tumor therapy research progress
by: Tong Zhao, et al.
Published: (2022-01-01)

Overcoming T-cell exhaustion in glioblastoma: A narrative review
by: Xuya Wang, et al.
Published: (2022-01-01)

Clofazimine enhances anti-PD-1 immunotherapy in glioblastoma by inhibiting Wnt6 signaling and modulating the tumor immune microenvironment
by: Yuze Zhao, et al.
Published: (2025-03-01)

The Biophysics of Flash Radiotherapy: Tools for Measuring Tumor and Normal Tissues Microenvironment
by: Islam G. Ali, et al.
Published: (2025-07-01)

γδ T cells as a potential therapeutic agent for glioblastoma
by: In Kang, et al.
Published: (2023-10-01)

Extracellular Vesicles in Glioblastoma Tumor Microenvironment
by: Anuroop Yekula, et al.
Published: (2020-01-01)

Involvement of Cyclooxygenase-2 in Establishing an Immunosuppressive Microenvironment in Tumorspheres Derived from TMZ-Resistant Glioblastoma Cell Lines and Primary Cultures
by: Francesca Lombardi, et al.
Published: (2024-01-01)

Oxygen-carrying nanoplatform to reprogram tumor immunosuppressive microenvironment and enhance photothermal-immunotherapy
by: Ju Huang, et al.
Published: (2023-04-01)

Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development
by: Changwu Wu, et al.
Published: (2022-07-01)

Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
by: Areez Shafqat, et al.
Published: (2023-07-01)

Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment
by: Andrea Franson, et al.
Published: (2022-09-01)

Immune microenvironments differ in immune characteristics and outcome of glioblastoma multiforme
by: Botao Zhang, et al.
Published: (2019-06-01)

Research progress on the role of PTEN deletion or mutation in the immune microenvironment of glioblastoma
by: Leiya Du, et al.
Published: (2024-08-01)

Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma
by: Jun Yang, et al.
Published: (2025-04-01)

Corrigendum: Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
by: Areez Shafqat, et al.
Published: (2023-07-01)

Navigating the immunosuppressive brain tumor microenvironment using spatial biology
by: Samuel S. Widodo, et al.
Published: (2024-09-01)

Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment
by: Jie Dai, et al.
Published: (2024-02-01)

Prospects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma
by: Tietze Stefanie, et al.
Published: (2021-04-01)

The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy
by: Erica C. F. Yeo, et al.
Published: (2021-03-01)

Inhibiting interferon-γ induced cancer intrinsic TNFRSF14 elevation restrains the malignant progression of glioblastoma
by: Yunhe Han, et al.
Published: (2024-07-01)

Immunosuppressive tumor microenvironment and advance in immunotherapy in melanoma bone metastasis
by: Yiqun Ma, et al.
Published: (2025-08-01)

Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape
by: Julio F. Inocencio, et al.
Published: (2024-09-01)

The Vascular Microenvironment in Glioblastoma: A Comprehensive Review
by: Alejandra Mosteiro, et al.
Published: (2022-05-01)